Table 2.
Incidence of key complications in patients diagnosed with MDS in the United States, 2001–2002
| Complicationa | Months to first occurrence |
3-Month cumulative incidenceb |
3-Year cumulative incidenceb |
|||
| Median | IQR | % | 95% CI | % | 95% CI | |
| Anemia | 5 | 2–6 | 28 | 23–33 | 81 | 76–86 |
| Neutropenia | 16 | 5–39 | 5 | 4–6 | 25 | 22–28 |
| Thrombocytopenia | 15 | 5–39 | 9 | 8–11 | 41 | 38–44 |
a
Among patients without the complication by the time of MDS diagnosis.
b
Estimated by Kaplan–Meier method.
MDS, myelodysplastic syndromes; CI, confidence interval; IQR, interquartile range.